You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

osteosarcoma

Showing 26 - 50 of 517
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neuroblastoma, Osteosarcoma Trial in Chapel Hill (iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine)

Recruiting
  • Neuroblastoma
  • Osteosarcoma
  • iC9.GD2.CAR.IL-15 T-cells
  • +2 more
  • Atlanta, Georgia
  • +1 more
Jan 4, 2023

Recurrent Osteosarcoma Trial in Los Angeles, New York, Houston (humanized anti-GD2 antibody, GM-CSF)

Recruiting
  • Recurrent Osteosarcoma
  • humanized anti-GD2 antibody
  • GM-CSF
  • Los Angeles, California
  • +2 more
Dec 22, 2022

Ewing Sarcoma, Ewing Sarcoma of Bone, Ewing Sarcoma of Soft Tissue Trial in United States (FoundationOne Liquid CDx)

Recruiting
  • Ewing Sarcoma
  • +6 more
  • FoundationOne Liquid CDx
  • Los Angeles, California
  • +14 more
Oct 5, 2023

Osteosarcoma Trial in Bengaluru (Extracorporeal shockwave device, No ESWT)

Completed
  • Osteosarcoma
  • Extracorporeal shockwave device
  • No ESWT
  • Bengaluru, Karnataka, India
    Dr. Roxanne
Mar 24, 2023

The Prognostic Value of Serum Biomarkers in Osteosarcoma

Completed
  • Osteosarcoma
  • case series review of clinical data
  • Bologna, BO, Italy
    IRCCS Itituto Ortopedico Rizzoli
Mar 25, 2022

Sarcoma Trial in Guangzhou (Surufatinib)

Recruiting
  • Sarcoma
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
May 5, 2022

Recurrent Neuroblastoma, Recurrent Osteosarcoma, Refractory Neuroblastoma Trial in Bethesda, Seattle, Madison (Cyclophosphamide,

Recruiting
  • Recurrent Neuroblastoma
  • +3 more
  • Palo Alto, California
  • +3 more
Jan 25, 2023

Localized Osteosarcoma, Metastatic Osteosarcoma, Resectable Osteosarcoma Trial (Bone Scan, Cabozantinib S-malate, Cisplatin)

Not yet recruiting
  • Localized Osteosarcoma
  • +3 more
  • Bone Scan
  • +7 more
  • (no location specified)
Jan 18, 2023

Osteosarcoma Trial in Italy (Mifamurtide arm, 3 drugs arm)

Active, not recruiting
  • Osteosarcoma
  • Mifamurtide arm
  • 3 drugs arm
  • Candiolo, Torino, Italy
  • +10 more
Sep 16, 2022

High Dose Isofosfamide Through Elastomer

Active, not recruiting
  • Osteosarcoma Recurrent
  • Observational study
  • Bologna, Italy
  • +4 more
Aug 11, 2022

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Chordoma, Chondrosarcoma, Ewing Sarcoma Trial in Nice (Proteus ONE one daily beam, Proteus ONE two daily beam)

Recruiting
  • Chordoma
  • +3 more
  • Proteus ONE one daily beam
  • Proteus ONE two daily beam
  • Nice, France
    Centre Antoine lacassagne
Sep 14, 2023

Survival Outcomes in Patients With Osteosarcoma

Recruiting
  • Osteosarcoma
  • Prediction model
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Jan 15, 2022

High Risk Neuroblastoma, Recurrent Neuroblastoma, Recurrent Osteosarcoma Trial in Canada, United States (Dinutuximab,

Recruiting
  • High Risk Neuroblastoma
  • +4 more
  • Biospecimen Collection
  • +6 more
  • Los Angeles, California
  • +10 more
Jan 19, 2023

Neuroblastoma, Osteosarcoma, Other Solid Tumor Cancers Trial in New York (Humanized 3F8 Bispecific Antibody, Blood draw)

Terminated
  • Neuroblastoma
  • +2 more
  • Humanized 3F8 Bispecific Antibody
  • Blood draw
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jul 11, 2022

Sarcoma, Osteosarcoma, Neuroblastoma Trial run by the NCI (Anti-GD2-CAR engineered T cells, AP1903, Cyclophosphamide)

Completed
  • Sarcoma
  • +3 more
  • Anti-GD2-CAR engineered T cells
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Osteogenic Sarcoma Recurrent Trial in Hackensack, Houston (Iscador*P)

Not yet recruiting
  • Osteogenic Sarcoma Recurrent
  • Hackensack, New Jersey
  • +1 more
Feb 3, 2023

Osteosarcoma Trial in France, United States (ZN-c3, Gemcitabine)

Recruiting
  • Osteosarcoma
  • Los Angeles, California
  • +15 more
Aug 9, 2022

Liver Transplant; Complications, Hepatocarcinoma, Recurrent Osteosarcoma Trial in Beijing (multi-kinase inhibitors in

Not yet recruiting
  • Liver Transplant; Complications
  • +3 more
  • multi-kinase inhibitors in combination with bevacizumab
  • Beijing, Beijing, China
    Chinese Academy of Medical Sciences & Peking Union Medical Colle
Sep 11, 2023

Effect of Drug, Drug, Toxicity Trial in Beijing (Apatinib+IE, IE)

Recruiting
  • Effect of Drug
  • +2 more
  • Beijing, Beijing, China
  • +1 more
Mar 12, 2022

Effect of Drug, Toxicity, Drug, Secondary Resistance Trial in Beijing (Apatinib Mesylate, ifosfamide and etoposide)

Completed
  • Effect of Drug
  • +2 more
  • Apatinib Mesylate
  • ifosfamide and etoposide
  • Beijing, Beijing, China
    Peking University People's Hospital
Mar 12, 2022

Osteosarcoma Trial in France (Mifamurtide, EI or M-API regimen depending on patient age)

Recruiting
  • Osteosarcoma
  • Amiens, France
  • +30 more
Dec 8, 2022

Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))

Recruiting
  • Osteosarcoma
  • +3 more
  • Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
  • Xi'an, Shaanxi, China
    Xi'an Honghui Hospital
May 8, 2023

Pediatric PET/MR Image Registry

Recruiting
  • Soft Tissue
  • +2 more
  • PET/MR imaging
  • +2 more
  • Palo Alto, California
    Stanford University, School of Medicine
Sep 9, 2022

Personalized Home Exercise Program in Bone Tumor Undergoing

Recruiting
  • Osteosarcoma
  • +3 more
    • Bologna, Italy
      Istituto Ortopedico Rizzoli
    Mar 21, 2023